On December 11, 2024, a bill was introduced in the U.S. House of Representatives that, if enacted, would have substantial implications for pharmacy benefit managers (“PBMs”) and pharmacies across the country. Titled the...more
2/13/2025
/ Antitrust Division ,
Competition ,
Department of Justice (DOJ) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Monopolization ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Proposed Legislation
Recent reports published by the Senate Budget Committee (the “Committee”) and the U.S. Department of Health and Human Services (“HHS”) highlight what the authors characterize as concerns related to private equity (“PE”)...more
2/11/2025
/ Acquisition Agreements ,
Competition ,
Department of Health and Human Services (HHS) ,
Enforcement Actions ,
Health Care Providers ,
Healthcare ,
Hospital Mergers ,
Hospitals ,
Merger Agreements ,
Private Equity ,
Regulatory Oversight ,
Regulatory Requirements